TABLE 1.
Clinical Characteristics of ITT‐LDLT and ITT‐DDLT Groups at Time of Listing
| ITT‐DDLT Group (n = 113) | ITT‐LDLT Group (n = 212) | P Value | |
|---|---|---|---|
| Age (years) | 55.5 (34.6‐72.5) | 56.7 (24.9‐75.8) | 0.684 |
| Recipient sex male (n, %) | 97 (85.8) | 157 (74.1) | 0.014 |
| Recipient BMI (kg/m2) | 24 (17‐43.9) | 24.5 (16.4‐42.9) | 0.913 |
| Hepatitis B virus (n, %) | 89 (78.8) | 164 (77.4) | 0.772 |
| Hepatitis C virus (n, %) | 3 (2.7) | 4 (1.9) | 0.958 |
| Disease indication (n, %) | 0.024 | ||
| Acute liver failure | 10 (8.8) | 20 (9.4) | |
| Acute on chronic liver failure | 38 (33.6) | 98 (46.2) | |
| Decompensated cirrhosis | 53 (46.9) | 73 (34.4) | |
| With concomitant HCC | 9 (8) | 7 (3.3) | |
| Others | 3 (2.7) | 14 (6.6) | |
| At listing | |||
| Bilirubin (μmol/L) | 443 (59‐1,044) | 434.5 (29‐949) | 0.508 |
| INR | 2.7 (1.5‐8) | 3 (1.4‐10) | 0.156 |
| Creatinine (μmol/L) | 155 (74‐766) | 136 (62‐1,022) | 0.055 |
| eGFR (mL/min/1.73 m2)* | 42.8 (5.8‐138) | 48.2 (4.3‐136.5) | 0.089 |
| <30 | 41 (36.3) | 67 (31.6) | |
| 30‐60 | 37 (32.7) | 54 (25.5) | |
| >60 | 35 (31) | 91 (42.9) | |
| MELD at listing | 34.2 (25.2‐51.2) | 34.1 (25.2‐55) | 0.840 |
| MELD > 35 at listing (n, %) | 52 (46) | 91 (42.9) | 0.593 |
| HRS (n, %) | 74 (65.5) | 113 (53.8) | 0.034 |
Note: Data are presented as n (%) or median (range).
*
eGFR was based on the Modification of Diet in Renal Disease equation.